Long-term risk for device-related complications and reoperations after implantable cardioverter-defibrillator implantation: An observational cohort study

Annals of Internal Medicine

Volumn 165, Issue 1, 2016, Pages 20-29

  Ranasinghe, Isuru ^a   Parzynski, Craig S ^b   Freeman, James V ^b   Dreyer, Rachel P ^b   Ross, Joseph S ^b   Akar, Joseph G ^b   Krumholz, Harlan M ^b   Curtis, Jeptha P ^b  

^a QUEEN ELIZABETH HOSPITAL   (Australia)

^b Center for Outcomes Research and Evaluation   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

AGED; ARTICLE; CARDIAC RESYNCHRONIZATION THERAPY; CARDIOVASCULAR MORTALITY; COHORT ANALYSIS; CONTROLLED STUDY; DEVICE INFECTION; DUAL CHAMBER PACEMAKER; ENDOCARDITIS; FEMALE; FOLLOW UP; HEART FAILURE; HEART PERFORATION; HEART VENTRICLE TACHYCARDIA; HOSPITAL; HOSPITALIZATION; HUMAN; IMPLANTABLE CARDIOVERTER DEFIBRILLATOR; IMPLANTATION; INCIDENCE; MAJOR CLINICAL STUDY; MALE; MEDICAL DEVICE COMPLICATION; MEDICARE; NEW YORK HEART ASSOCIATION CLASS; OBSERVATIONAL STUDY; PERICARDIAL EFFUSION; PLEURA EFFUSION; PNEUMOTHORAX; PRIMARY PREVENTION; PRIORITY JOURNAL; REOPERATION; RISK FACTOR; SECONDARY PREVENTION; SURVIVAL TIME; THROMBOEMBOLISM; UNITED STATES; VEIN OCCLUSION; VERY ELDERLY;

EID: 84978036709     PISSN: 00034819     EISSN: 15393704     Source Type: Journal    
DOI: 10.7326/M15-2732     Document Type: Article

References (31)

1. Ezekowitz JA, Rowe BH, Dryden DM, Hooton N, Vandermeer B, Spooner C, et al. Systematic review: implantable cardioverter defi- brillators for adults with left ventricular systolic dysfunction. Ann Intern Med. 2007;147:251-62. [PMID: 17709759]
2. Reynolds MR, Cohen DJ, Kugelmass AD, Brown PP, Becker ER, Culler SD, et al. The frequency and incremental cost of major complications among Medicare beneficiaries receiving implantable cardioverter-defibrillators. J Am Coll Cardiol. 2006;47:2493-7. [PMID: 16781379]
3. Lee DS, Krahn AD, Healey JS, Birnie D, Crystal E, Dorian P, et al. Investigators of the Ontario ICD Database. Evaluation of early complications related to de novo cardioverter defibrillator implantation insights from the Ontario ICD database. J Am Coll Cardiol. 2010;55: 774-82. [PMID: 20170816] doi:10.1016/j.jacc.2009.11.029
4. Al-Khatib SM, Greiner MA, Peterson ED, Hernandez AF, Schulman KA, Curtis LH. Patient and implanting physician factors associated with mortality and complications after implantable cardioverterdefibrillator implantation, 2002-2005. Circ Arrhythm Electrophysiol. 2008;1:240-9. [PMID: 19169382] doi:10.1161/CIRCEP.108.777888
5. Moss AJ, Zareba W, Hall WJ, Klein H, Wilber DJ, Cannom DS, et al. Multicenter Automatic Defibrillator Implantation Trial II Investigators. Prophylactic implantation of a defibrillator in patients with myocardial infarction and reduced ejection fraction. N Engl J Med. 2002;346:877-83. [PMID: 11907286]
6. Bardy GH, Lee KL, Mark DB, Poole JE, Packer DL, Boineau R, et al. Sudden Cardiac Death in Heart Failure Trial (SCD-HeFT) Investigators. Amiodarone or an implantable cardioverter-defibrillator for congestive heart failure. N Engl J Med. 2005;352:225-37. [PMID: 15659722]
7. Hlatky MA, Saynina O, McDonald KM, Garber AM, McClellan MB. Utilization and outcomes of the implantable cardioverter defibrillator, 1987 to 1995. Am Heart J. 2002;144:397-403. [PMID: 12228775]
8. Anderson KP. Estimates of implantable cardioverter-defibrillator complications: caveat emptor [Editorial]. Circulation. 2009;119: 1069-71. [PMID: 19255352] doi:10.1161/CIRCULATIONAHA.108 .841452
9. Brignole M. Are complications of implantable defibrillators underestimated and benefits over-estimated? [Editorial]. Europace. 2009; 11:1129-33. [PMID: 19578174] doi:10.1093/europace/eup174
10. Hauptman PJ, Chibnall JT, Guild C, Armbrecht ES. Patient perceptions, physician communication, and the implantable cardioverter-defibrillator. JAMA Intern Med. 2013;173:571-7. [PMID: 23420455] doi:10.1001/jamainternmed.2013.3171
11. Kramer DB, Kennedy KF, Noseworthy PA, Buxton AE, Josephson ME, Normand SL, et al. Characteristics and outcomes of patients receiving new and replacement implantable cardioverterdefibrillators: results from the NCDR. Circ Cardiovasc Qual Outcomes. 2013;6:488-97. [PMID: 23759471] doi:10.1161/CIRCOUTCOMES.111.000054
12. Hammill SC, Kremers MS, Kadish AH, Stevenson LW, Heidenreich PA, Lindsay BD, et al. Review of the ICD Registry's third year, expansion to include lead data and pediatric ICD procedures, and role for measuring performance. Heart Rhythm. 2009;6:1397-401. [PMID: 19716099] doi:10.1016/j.hrthm.2009.07.015
13. Kremers MS, Hammill SC, Berul CI, Koutras C, Curtis JS, Wang Y, et al. The National ICD Registry Report: version 2.1 including leads and pediatrics for years 2010 and 2011. Heart Rhythm. 2013;10:e59-65. [PMID: 23403056] doi:10.1016/j.hrthm.2013.01.035
14. Poole JE, Gleva MJ, Mela T, Chung MK, Uslan DZ, Borge R, et al. REPLACE Registry Investigators. Complication rates associated with pacemaker or implantable cardioverter-defibrillator generator replacements and upgrade procedures: results from the REPLACE registry. Circulation. 2010;122:1553-61. [PMID: 20921437] doi:10 .1161/CIRCULATIONAHA.110.976076
15. Kramer DB, Kennedy KF, Spertus JA, Normand SL, Noseworthy PA, Buxton AE, et al. Mortality risk following replacement implantable cardioverter-defibrillator implantation at end of battery life: results from the NCDR. Heart Rhythm. 2014;11:216-21. [PMID: 24513917]
16. Gray RJ. A class of k-sample tests for comparing the cumulative incidence of a competing risk. Ann Stat. 1988;16:1141-54.
17. Fine JP, Gray RJ. A proportional hazards model for the subdistribution of a competing risk. J Am Stat Assoc. 1999;94:496-509.
18. Hosmer DW, Lemeshow S. Applied Survival Analysis: Regression Modeling of Time to Event Data. New York: J Wiley; 1999.
19. Ezzat VA, Lee V, Ahsan S, Chow AW, Segal O, Rowland E, et al. A systematic review of ICD complications in randomised controlled trials versus registries: is our real-world data an underestimation? Open Heart. 2015;2:e000198. [PMID: 25745566] doi:10.1136/openhrt-2014-000198
20. Eckstein J, Koller MT, Zabel M, Kalusche D, Schaer BA, Osswald S, et al. Necessity for surgical revision of defibrillator leads implanted long-term: causes and management. Circulation. 2008;117:2727-33. [PMID: 18490526] doi:10.1161/CIRCULATIONAHA.107.740670
21. Kleemann T, Becker T, Doenges K, Vater M, Senges J, Schneider S, et al. Annual rate of transvenous defibrillation lead defects in implantable cardioverter-defibrillators over a period of >10 years. Circulation. 2007;115:2474-80. [PMID: 17470696]
22. Duray GZ, Schmitt J, Cicek-Hartvig S, Hohnloser SH, Israel CW. Complications leading to surgical revision in implantable cardioverter defibrillator patients: comparison of patients with singlechamber, dual-chamber, and biventricular devices. Europace. 2009; 11:297-302. [PMID: 19054788] doi:10.1093/europace/eun322
23. Landolina M, Gasparini M, Lunati M, Iacopino S, Boriani G, Bonanno C, et al. Cardiovascular Centers Participating in the ClinicalService Project. Long-term complications related to biventricular defibrillator implantation: rate of surgical revisions and impact on survival: insights from the Italian Clinical Service Database. Circulation. 2011;123:2526-35. [PMID: 21576653] doi:10.1161/CIRCULATIONAHA.110.015024
24. MacFadden DR, Crystal E, Krahn AD, Mangat I, Healey JS, Dorian P, et al. Sex differences in implantable cardioverterdefibrillator outcomes: findings from a prospective defibrillator database. Ann Intern Med. 2012;156:195-203. [PMID: 22312139] doi: 10.7326/0003-4819-156-3-201202070-00007
25. Trivedi AN, Sequist TD, Ayanian JZ. Impact of hospital volume on racial disparities in cardiovascular procedure mortality. J Am Coll Cardiol. 2006;47:417-24. [PMID: 16412871]
26. Lee DS, Tu JV, Austin PC, Dorian P, Yee R, Chong A, et al. Effect of cardiac and noncardiac conditions on survival after defibrillator implantation. J Am Coll Cardiol. 2007;49:2408-15. [PMID: 17599603]
27. Al-Khatib SM, Hellkamp A, Curtis J, Mark D, Peterson E, Sanders GD, et al. Non-evidence-based ICD implantations in the United States. JAMA. 2011;305:43-9. [PMID: 21205965] doi:10.1001/jama .2010.1915
28. Peterson PN, Varosy PD, Heidenreich PA, Wang Y, Dewland TA, Curtis JP, et al. Association of single- vs dual-chamber ICDs with mortality, readmissions, and complications among patients receiving an ICD for primary prevention. JAMA. 2013;309:2025-34. [PMID: 23677314] doi:10.1001/jama.2013.4982
29. Dewland TA, Pellegrini CN, Wang Y, Marcus GM, Keung E, Varosy PD. Dual-chamber implantable cardioverter-defibrillator selection is associated with increased complication rates and mortality among patients enrolled in the NCDR implantable cardioverterdefibrillator registry. J Am Coll Cardiol. 2011;58:1007-13. [PMID: 21867834] doi:10.1016/j.jacc.2011.04.039
30. Boriani G, Braunschweig F, Deharo JC, Leyva F, Lubinski A, Lazzaro C. Impact of extending device longevity on the long-term costs of implantable cardioverter-defibrillator therapy: a modelling study with a 15-year time horizon. Europace. 2013;15:1453-62. [PMID: 23696624] doi:10.1093/europace/eut133
31. Biffi M, Ziacchi M, Bertini M, Sangiorgi D, Corsini D, Martignani C, et al. Longevity of implantable cardioverter-defibrillators: implications for clinical practice and health care systems. Europace. 2008; 10:1288-95. [PMID: 18772164] doi:10.1093/europace/eun240